Segment Information (Tables)

9 Months Ended

Sep. 30, 2011

Segment Information

Reconciliation Of Segment Information To Total Consolidated Information

	Generics Segment		Specialty Segment		Corporate / Other (1)			Consolidated
	(In thousands)
Three Months Ended September 30, 2011
Total revenues
Third party	$	1,361,462	$	214,294	$	—		$	1,575,756
Intersegment		398		17,118		(17,516	)		—
Total	$	1,361,860	$	231,412	$	(17,516	)	$	1,575,756
Segment profitability	$	393,985	$	92,084	$	(220,161	)	$	265,908
	Generics Segment		Specialty Segment		Corporate / Other (1)			Consolidated
	(In thousands)
Nine Months Ended September 30, 2011
Total revenues
Third party	$	4,153,365	$	445,225	$	—		$	4,598,590
Intersegment		1,200		51,402		(52,602	)		—
Total	$	4,154,565	$	496,627	$	(52,602	)	$	4,598,590
Segment profitability	$	1,214,524	$	169,729	$	(626,200	)	$	758,053
	Generics Segment		Specialty Segment		Corporate / Other (1)			Consolidated
	(In thousands)
Three Months Ended September 30, 2010
Total revenues
Third party	$	1,213,216	$	141,897	$	—		$	1,355,113
Intersegment		2,392		13,689		(16,081	)		—
Total	$	1,215,608	$	155,586	$	(16,081	)	$	1,355,113
Segment profitability	$	357,393	$	49,761	$	(172,836	)	$	234,318

	Generics Segment		Specialty Segment		Corporate / Other (1)			Consolidated
	(In thousands)
Nine Months Ended September 30, 2010
Total revenues
Third party	$	3,663,733	$	352,290	$	—		$	4,016,023
Intersegment		34,314		47,419		(81,733	)		—
Total	$	3,698,047	$	399,709	$	(81,733	)	$	4,016,023
Segment profitability	$	1,015,980	$	104,881	$	(493,451	)	$	627,410

⁽¹⁾  Includes certain corporate general and administrative and research and development expenses; net charges for litigation settlements; certain intercompany transactions, including eliminations; amortization of intangible assets and certain purchase accounting items; impairment charges, if any; and other expenses not directly attributable to segments.